{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:32:02Z","timestamp":1793460722406,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82293664"],"award-info":[{"award-number":["82293664"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341212"],"award-info":[{"award-number":["82341212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31930039"],"award-info":[{"award-number":["31930039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01471-2","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:03:15Z","timestamp":1791867795000},"page":"1513-1528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPRa screen unveils noncanonical NF-\u03baB to boost the antitumor activity of TCR-based CAR-T cells"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4425-424X","authenticated-orcid":false,"given":"Hanyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-3654","authenticated-orcid":false,"given":"Xin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"1471_CR1","doi-asserted-by":"crossref","unstructured":"Barros LRC, Couto SCF, da Silva Santurio D, Paixao EA, Cardoso F, da Silva VJ, et al. Systematic review of available CAR-T cell trials around the world. Cancers. 2022;14:2667.","DOI":"10.3390\/cancers14112667"},{"key":"1471_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","volume":"20","author":"AJ Hou","year":"2021","unstructured":"Hou AJ, Chen LC, Chen YY. Navigating CAR-T cells through the solid-tumor microenvironment. Nat Rev Drug Discov. 2021;20:531\u201350.","journal-title":"Nat Rev Drug Discov"},{"key":"1471_CR3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","volume":"8","author":"RG Majzner","year":"2018","unstructured":"Majzner RG, Mackall CL. Tumor antigen escape from CAR T-cell therapy. Cancer Discov. 2018;8:1219\u201326.","journal-title":"Cancer Discov"},{"key":"1471_CR4","doi-asserted-by":"crossref","unstructured":"Safarzadeh Kozani P, Safarzadeh Kozani P, Ahmadi Najafabadi M, Yousefi F, Mirarefin SMJ, Rahbarizadeh F. Recent advances in solid tumor CAR-T-cell therapy: driving tumor cells from hero to zero? Front Immunol.\u00a02022;13:795164.","DOI":"10.3389\/fimmu.2022.795164"},{"key":"1471_CR5","doi-asserted-by":"crossref","unstructured":"Liu Y, Liu G, Wang J, Zheng ZY, Jia L, Rui W, et al. Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors. Sci Transl Med. 2021;13:eabb5191.","DOI":"10.1126\/scitranslmed.abb5191"},{"key":"1471_CR6","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/ajh.26586","volume":"97","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang X, Zhou Z, Liu Y, Yu L, Jia L, et al. A novel adoptive synthetic TCR and antigen receptor (STAR) T-Cell therapy for B-Cell acute lymphoblastic leukemia. Am J Hematol. 2022;97:992\u20131004.","journal-title":"Am J Hematol"},{"key":"1471_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41577-021-00539-6","volume":"21","author":"JD Chan","year":"2021","unstructured":"Chan JD, Lai J, Slaney CY, Kallies A, Beavis PA, Darcy PK. Cellular networks controlling T-cell persistence in adoptive cell therapy. Nat Rev Immunol. 2021;21:769\u201384.","journal-title":"Nat Rev Immunol"},{"key":"1471_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10097-0","volume":"10","author":"PA Baeuerle","year":"2019","unstructured":"Baeuerle PA, Ding J, Patel E, Thorausch N, Horton H, Gierut J, et al. Synthetic TRuC receptors engaging the complete T-cell receptor for potent anti-tumor response. Nat Commun. 2019;10:2087.","journal-title":"Nat Commun"},{"key":"1471_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41591-021-01621-1","volume":"28","author":"J Mansilla-Soto","year":"2022","unstructured":"Mansilla-Soto J, Eyquem J, Haubner S, Hamieh M, Feucht J, Paillon N, et al. HLA-independent T-cell receptors for targeting tumors with low antigen density. Nat Med. 2022;28:345\u201352.","journal-title":"Nat Med"},{"key":"1471_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/imr.12657","volume":"283","author":"JL Reading","year":"2018","unstructured":"Reading JL, Galvez-Cancino F, Swanton C, Lladser A, Peggs KS, Quezada SA. The function and dysfunction of memory CD8(+) T cells in tumor immunity. Immunol Rev. 2018;283:194\u2013212.","journal-title":"Immunol Rev"},{"key":"1471_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109078","volume":"241","author":"F Wang","year":"2022","unstructured":"Wang F, Cheng F, Zheng F. Stem cell like memory T cells: A new paradigm in cancer immunotherapy. Clin Immunol. 2022;241:109078.","journal-title":"Clin Immunol"},{"key":"1471_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2020","unstructured":"Kallies A, Zehn D, Utzschneider DT. Precursor exhausted T cells: key to successful immunotherapy? Nat Rev Immunol. 2020;20:128\u201336.","journal-title":"Nat Rev Immunol"},{"key":"1471_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im SJ, Hashimoto M, Gerner MY, Lee J, Kissick HT, Burger MC, et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature. 2016;537:417\u201321.","journal-title":"Nature"},{"key":"1471_CR14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2021.02.019","volume":"184","author":"Z Chen","year":"2021","unstructured":"Chen Z, Arai E, Khan O, Zhang Z, Ngiow SF, He Y, et al. In vivo CD8(+) T-cell CRISPR screening reveals control by Fli1 in infection and cancer. Cell. 2021;184:1262\u201380 e22.","journal-title":"Cell"},{"key":"1471_CR15","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2019.07.044","volume":"178","author":"MB Dong","year":"2019","unstructured":"Dong MB, Wang G, Chow RD, Ye L, Zhu L, Dai X, et al. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178:1189\u2013204 e23.","journal-title":"Cell"},{"key":"1471_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu B, Hu X, Feng K, Gao R, Xue Z, Zhang S, et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer. 2022;3:108\u201321.","journal-title":"Nat Cancer"},{"key":"1471_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, et al. Pancancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374:abe6474.","journal-title":"Science"},{"key":"1471_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"key":"1471_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"SC Sun","year":"2017","unstructured":"Sun SC. The noncanonical NF-kappaB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17:545\u201358.","journal-title":"Nat Rev Immunol"},{"key":"1471_CR20","doi-asserted-by":"crossref","unstructured":"Philipson BI, O\u2019Connor RS, May MJ, June CH, Albelda SM, Milone MC. 4-1BB costimulation promotes CAR T-cell survival through noncanonical NF-kappaB signaling. Sci Signal. 2020;13:eaay8248.","DOI":"10.1126\/scisignal.aay8248"},{"key":"1471_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.764164","volume":"9","author":"G Ghosh","year":"2021","unstructured":"Ghosh G, Wang VY. Origin of the functional distinctiveness of NF-kappaB\/p52. Front Cell Dev Biol. 2021;9:764164.","journal-title":"Front Cell Dev Biol"},{"key":"1471_CR22","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1038\/sj.onc.1209933","volume":"25","author":"A Hoffmann","year":"2006","unstructured":"Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene. 2006;25:6706\u201316.","journal-title":"Oncogene"},{"key":"1471_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et al. Tumor-associated B7-H1 promotes T-apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793\u2013800.","journal-title":"Nat Med"},{"key":"1471_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm.3838","volume":"21","author":"AH Long","year":"2015","unstructured":"Long AH, Haso WM, Shern JF, Wanhainen KM, Murgai M, Ingaramo M, et al. 4-1BB costimulation ameliorates T-cell exhaustion induced by tonic signaling of chimeric antigen receptors. Nat Med. 2015;21:581\u201390.","journal-title":"Nat Med"},{"key":"1471_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.celrep.2017.09.015","volume":"21","author":"D Gomes-Silva","year":"2017","unstructured":"Gomes-Silva D, Mukherjee M, Srinivasan M, Krenciute G, Dakhova O, Zheng Y, et al. Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T-Cell Survival and Is Vector Dependent. Cell Rep. 2017;21:17\u201326.","journal-title":"Cell Rep"},{"key":"1471_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0280-5","volume":"8","author":"KA de Oliveira","year":"2016","unstructured":"de Oliveira KA, Kaergel E, Heinig M, Fontaine JF, Patone G, Muro EM, et al. A roadmap of constitutive NF-kappaB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses. Genome Med. 2016;8:28.","journal-title":"Genome Med"},{"key":"1471_CR27","doi-asserted-by":"crossref","unstructured":"Wang B, Wang Y, Sun X, Deng G, Huang W, Wu X, et al. CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell. J Immunother Cancer. 2021;9:e003100.","DOI":"10.1136\/jitc-2021-003100"},{"key":"1471_CR28","doi-asserted-by":"crossref","unstructured":"Chow MT, Ozga AJ, Servis RL, Frederick DT, Lo JA, Fisher DE, et al. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of Anti-PD-1 therapy. Immunity. 2019;50:1498\u2013512.e5.","DOI":"10.1016\/j.immuni.2019.04.010"},{"key":"1471_CR29","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1038\/s41375-019-0464-2","volume":"33","author":"F Chu","year":"2019","unstructured":"Chu F, Li HS, Liu X, Cao J, Ma W, Ma Y, et al. CXCR5(+)CD8(+) T cells are a distinct functional subset with an antitumor activity. Leukemia. 2019;33:2640\u201353.","journal-title":"Leukemia"},{"key":"1471_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109438","volume":"36","author":"IH Seo","year":"2021","unstructured":"Seo IH, Eun HS, Kim JK, Lee H, Jeong S, Choi SJ, et al. IL-15 enhances CCR5-mediated migration of memory CD8(+) T cells by upregulating CCR5 expression in the absence of TCR stimulation. Cell Rep. 2021;36:109438.","journal-title":"Cell Rep"},{"key":"1471_CR31","doi-asserted-by":"crossref","unstructured":"Karaki S, Blanc C, Tran T, Galy Fauroux I, Mougel A, Dransart E, et al. CXCR6 deficiency impairs cancer vaccine efficacy and CD8(+) resident memory T-cell recruitment in head and neck and lung tumors. J Immunother Cancer. 2021;9:e001948.","DOI":"10.1136\/jitc-2020-001948"},{"key":"1471_CR32","doi-asserted-by":"publisher","first-page":"12410","DOI":"10.1073\/pnas.1905675116","volume":"116","author":"H Seo","year":"2019","unstructured":"Seo H, Chen J, Gonzalez-Avalos E, Samaniego-Castruita D, Das A, Wang YH, et al. TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T-cell exhaustion. Proc Natl Acad Sci USA. 2019;116:12410\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1471_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-019-0979-8","volume":"567","author":"X Liu","year":"2019","unstructured":"Liu X, Wang Y, Lu H, Li J, Yan X, Xiao M, et al. Genome-wide analysis identifies NR4A1 as a key mediator of T-cell dysfunction. Nature. 2019;567:525\u20139.","journal-title":"Nature"},{"key":"1471_CR34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","volume":"47","author":"K Man","year":"2017","unstructured":"Man K, Gabriel SS, Liao Y, Gloury R, Preston S, Henstridge DC, et al. Transcription factor IRF4 promotes CD8(+) T-cell exhaustion and limits the development of memory-like T cells during chronic infection. Immunity. 2017;47:1129\u201341 e5.","journal-title":"Immunity"},{"key":"1471_CR35","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1182\/blood.2021012714","volume":"139","author":"T Yoshikawa","year":"2022","unstructured":"Yoshikawa T, Wu Z, Inoue S, Kasuya H, Matsushita H, Takahashi Y, et al. Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy. Blood. 2022;139:2156\u201372.","journal-title":"Blood"},{"key":"1471_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","volume":"564","author":"X Meng","year":"2018","unstructured":"Meng X, Liu X, Guo X, Jiang S, Chen T, Hu Z, et al. FBXO38 mediates PD-1 ubiquitination and regulates antitumor immunity of T cells. Nature. 2018;564:130\u20135.","journal-title":"Nature"},{"key":"1471_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41590-020-00829-6","volume":"22","author":"M Gu","year":"2021","unstructured":"Gu M, Zhou X, Sohn JH, Zhu L, Jie Z, Yang JY, et al. NF-kappaB-inducing kinase maintains T-cell metabolic fitness in antitumor immunity. Nat Immunol. 2021;22:193\u2013204.","journal-title":"Nat Immunol"},{"key":"1471_CR38","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","volume":"173","author":"JM Chemnitz","year":"2004","unstructured":"Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T-cell stimulation, but only receptor ligation prevents T-cell activation. J Immunol. 2004;173:945\u201354.","journal-title":"J Immunol"},{"key":"1471_CR39","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","volume":"1","author":"A Oeckinghaus","year":"2009","unstructured":"Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol. 2009;1:a000034.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1471_CR40","doi-asserted-by":"publisher","first-page":"8708","DOI":"10.1074\/jbc.274.13.8708","volume":"274","author":"AM Sheehy","year":"1999","unstructured":"Sheehy AM, Schlissel MS. Overexpression of RelA causes G1 arrest and apoptosis in a pro-B-cell line. J Biol Chem. 1999;274:8708\u201316.","journal-title":"J Biol Chem"},{"key":"1471_CR41","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1038\/sj.onc.1205536","volume":"21","author":"D Bernard","year":"2002","unstructured":"Bernard D, Monte D, Vandenbunder B, Abbadie C. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD. Oncogene. 2002;21:4392\u2013402.","journal-title":"Oncogene"},{"key":"1471_CR42","doi-asserted-by":"crossref","unstructured":"Gallagher MP, Conley JM, Vangala P, Garber M, Reboldi A, Berg LJ. Hierarchy of signaling thresholds downstream of the T-cell receptor and the Tec kinase ITK. Proc Natl Acad Sci USA. 2021;118:e2025825118.","DOI":"10.1073\/pnas.2025825118"},{"key":"1471_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1646","volume":"16","author":"BN Rodriguez","year":"2024","unstructured":"Rodriguez BN, Huang H, Chia JJ, Hoffmann A. The noncanonical NFkappaB pathway: regulatory mechanisms in health and disease. WIREs Mech Dis. 2024;16:e1646.","journal-title":"WIREs Mech Dis"},{"key":"1471_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41421-024-00767-9","volume":"11","author":"HI Navarro","year":"2025","unstructured":"Navarro HI, Daly AE, Rodriguez B, Wu S, Ngo KA, Fraser A, et al. NF-kappaB RelB suppresses the inflammatory gene expression programs of dendritic cells by competing with RelA for binding to target gene promoters. Cell Discov. 2025;11:13.","journal-title":"Cell Discov"},{"key":"1471_CR45","doi-asserted-by":"crossref","unstructured":"Liu J, Wei L, Hu N, Wang D, Ni J, Zhang S, et al. FBW7-mediated ubiquitination and destruction of PD-1 protein primes sensitivity to anti-PD-1 immunotherapy in non-small cell lung cancer. J Immunother Cancer. 2022;10:e005116.","DOI":"10.1136\/jitc-2022-005116"},{"key":"1471_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adp7302","volume":"9","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Ren C, Xiao R, Ma S, Liu H, Dou Y, et al. Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity. Sci Immunol. 2024;9:eadp7302.","journal-title":"Sci Immunol"},{"key":"1471_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","volume":"42","author":"GJ Martinez","year":"2015","unstructured":"Martinez GJ, Pereira RM, Aijo T, Kim EY, Marangoni F, Pipkin ME, et al. The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells. Immunity. 2015;42:265\u201378.","journal-title":"Immunity"},{"key":"1471_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1084\/jem.186.1.47","volume":"186","author":"WW Shuford","year":"1997","unstructured":"Shuford WW, Klussman K, Tritchler DD, Loo DT, Chalupny J, Siadak AW, et al. 4-1BB costimulatory signals preferentially induce CD8+ T-cell proliferation and lead to the amplification in vivo of cytotoxic T-cell responses. J Exp Med. 1997;186:47\u201355.","journal-title":"J Exp Med"},{"key":"1471_CR49","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","volume":"44","author":"JH Esensten","year":"2016","unstructured":"Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28 costimulation: from mechanism to therapy. Immunity. 2016;44:973\u201388.","journal-title":"Immunity"},{"key":"1471_CR50","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","volume":"18","author":"B Rayet","year":"1999","unstructured":"Rayet B, Gelinas C. Aberrant rel\/nfkb genes and activity in human cancer. Oncogene. 1999;18:6938\u201347.","journal-title":"Oncogene"},{"key":"1471_CR51","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1084\/jem.186.7.999","volume":"186","author":"H Ishikawa","year":"1997","unstructured":"Ishikawa H, Carrasco D, Claudio E, Ryseck RP, Bravo R. Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. J Exp Med. 1997;186:999\u20131014.","journal-title":"J Exp Med"},{"key":"1471_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24488-8","volume":"8","author":"JA Saxon","year":"2018","unstructured":"Saxon JA, Yu H, Polosukhin VV, Stathopoulos GT, Gleaves LA, McLoed AG, et al. p52 expression enhances lung cancer progression. Sci Rep. 2018;8:6078.","journal-title":"Sci Rep"},{"key":"1471_CR53","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.4049\/jimmunol.1501555","volume":"196","author":"JA Saxon","year":"2016","unstructured":"Saxon JA, Cheng DS, Han W, Polosukhin VV, McLoed AG, Richmond BW, et al. p52 Overexpression Increases Epithelial Apoptosis, Enhances Lung Injury, and Reduces Survival after Lipopolysaccharide Treatment. J Immunol. 2016;196:1891\u20139.","journal-title":"J Immunol"},{"key":"1471_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07901-8","volume":"9","author":"KR Sanson","year":"2018","unstructured":"Sanson KR, Hanna RE, Hegde M, Donovan KF, Strand C, Sullender ME, et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun. 2018;9:5416.","journal-title":"Nat Commun"},{"key":"1471_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj4008","volume":"375","author":"R Schmidt","year":"2022","unstructured":"Schmidt R, Steinhart Z, Layeghi M, Freimer JW, Bueno R, Nguyen VQ, et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science. 2022;375:eabj4008.","journal-title":"Science"},{"key":"1471_CR56","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1093\/bioinformatics\/bty450","volume":"34","author":"CH Chen","year":"2018","unstructured":"Chen CH, Xiao T, Xu H, Jiang P, Meyer CA, Li W, et al. Improved design and analysis of CRISPR knockout screens. Bioinformatics. 2018;34:4095\u2013101.","journal-title":"Bioinformatics"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01471-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01471-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01471-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:09:43Z","timestamp":1793459383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01471-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["1471"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01471-2","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"XL, HY, YL and JW filed a patent related to the technology described in this paper. The other authors declare that they have no competing interests. No authors have participated in paid or unpaid consulting. XL is an editorial board member of Cellular & Molecular Immunology, but he has not been involved in peer review or decision-making related to the article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}